Evidence map›Paper›PMID 37443720›Full record

ReviewCells2023

The Importance of Stem Cells Isolated from Human Dental Pulp and Exfoliated Deciduous Teeth as Therapeutic Approach in Nervous System Pathologies.

Niccolò Candelise, Francesca Santilli, Jessica Fabrizi, Daniela Caissutti, Zaira Spinello, Camilla Moliterni, Loreto Lancia, Simona Delle Monache, Vincenzo Mattei, Roberta Misasi

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in cell and developmental biology · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Niccolò CandeliseNational Center for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.
Francesca SantilliBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy.ORCID 0000-0003-0863-2996
Jessica FabriziBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy.
Daniela CaissuttiDepartment Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
Zaira SpinelloDepartment Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
Camilla MoliterniDepartment of Neuroscience, Mental Health and Sensory Organs (NESMOS), "Sapienza" University of Rome, 00189 Rome, Italy.ORCID 0000-0002-7849-2119
Loreto LanciaDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Simona Delle MonacheDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-8153-915X
Vincenzo MatteiBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy.ORCID 0000-0003-4677-088X
Roberta MisasiDepartment Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
Sapienza University of Rome · ITUniversity of L'Aquila · ITIstituto Superiore di Sanità · IT

Funding

Fondazione Cassa di Risparmio di Pistoia e Pescia CUP B89J22001910007Istituto Superiore di Sanità CUP I83C22002190005
6 · The paper itself

Abstract

Despite decades of research, no therapies are available to halt or slow down the course of neuro-degenerative disorders. Most of the drugs developed to fight neurodegeneration are aimed to alleviate symptoms, but none has proven adequate in altering the course of the pathologies. Cell therapy has emerged as an intriguing alternative to the classical pharmacological approach. Cell therapy consists of the transplantation of stem cells that can be obtained from various embryonal and adult tissues. Whereas the former holds notable ethical issue, adult somatic stem cells can be obtained without major concerns. However, most adult stem cells, such as those derived from the bone marrow, are committed toward the mesodermal lineage, and hence need to be reprogrammed to induce the differentiation into the neurons. The discovery of neural crest stem cells in the dental pulp, both in adults' molar and in baby teeth (dental pulp stem cells and stem cells from human exfoliated deciduous teeth, respectively) prompted researchers to investigate their utility as therapy in nervous system disorders. In this review, we recapitulate the advancements on the application of these stem cells in preclinical models of neurodegenerative diseases, highlighting differences and analogies in their maintenance, differentiation, and potential clinical application.

Indexed as

Mesenchymal Stem CellsAdultDental PulpHumansNervous SystemStem CellsTooth, Deciduouscell therapydental pulp stem cellsDPSCsneurodegenerative diseasesSHEDsstem cellsstem cells from human exfoliated deciduous teeth

Identifiers

PMID37443720
PMCPMC10340170
OpenAlexW4381799873

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.